Enacts the manufacturer disclosure and transparency act
Summary
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2019
Committee Review
Floor Vote
Governor
Introduced Apr 12, 2019
Last action Feb 5, 2020
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
3
Amendments
1
Feb 5, 2020
Senate · Amendment adopted
PRINT NUMBER 5169A
Feb 5, 2020
Senate · Referred to committee
AMEND (T) AND RECOMMIT TO CONSUMER PROTECTION
Jan 8, 2020
Senate · Referred to committee
REFERRED TO CONSUMER PROTECTION
Apr 12, 2019
Senate · Referred to committee
REFERRED TO CONSUMER PROTECTION
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about S 5169
Scope: NY
Hi! I can help you understand S 5169. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline